How stressed cells boost production of key blood clotting factor
February 5th, 2011 - 5:17 pm ICT by ANIWashington, Feb 04 (ANI): Scientists have found how stressed cells boost the production of the key blood clotting factor, thrombin.
The discovery was made by scientists at the Molecular Medicine Partnership Unit (MMPU), a collaboration between the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and the University of Heidelberg Medical Centre.
Their work shows how cancer cells may be taking advantage of this process, and opens new possibilities for fighting back, not only against cancer but also against septicaemia, where increased blood clotting is still one of the leading causes of death.
“For the 1st time, we have something in hand that might explain this enigmatic relationship between enhanced pro-coagulatory activities and the outcome of cancer,” said Sven Danckwardt, who carried out the research within the MMPU.
The amount of thrombin our cells produce is controlled by two sets of proteins: proteins that slow thrombin production, and proteins that speed it up. Both types of protein act by binding to the cellular machinery that synthesises thrombin, and, under normal conditions, the production-slowing proteins keep thrombin levels low.
But Danckwardt and colleagues discovered that, when our cells come under stress from inflammation, another protein, called p38 MAPK, reacts by adding a chemical tag to those production-slowing proteins. That tag makes it harder for the production-slowing proteins to bind to the thrombin-synthesising machinery, allowing the proteins that speed up production to take over. So inflammation caused by cancer could lead to increased thrombin levels and, as thrombin is a blood-clotting agent, this could explain why cancer patients are more likely to suffer from blood-clots. The scientists believe this new mechanism of gene regulation may apply to other genes, too.
The study has been published in Molecular Cell. (ANI)
- Study finds how blood clotting and cancer progression are linked - Feb 05, 2011
- Cholesterol shows promise in fighting cancer - Apr 23, 2012
- Dental bugs may trigger fatal heart condition - Mar 26, 2012
- Fish oil may hold key to leukaemia cure - Dec 23, 2011
- Scientists find way to harness thrombin's anti-blood clotting properties - Jun 21, 2010
- Blood-clotting agent can be used to diagnose fatal genetic diseases - Feb 04, 2011
- Snake venom studies paves way for therapies for heart disease, cancer - Jul 30, 2010
- Newly mechanism that forms blood clots discovered - Dec 11, 2009
- DNA damage can help protect the body from infection - Apr 01, 2011
- 'Master switch' for key immune cells in inflammatory diseases found - Jan 17, 2011
- Key blood component produced from GM rice - Nov 06, 2011
- Scientists discover potential new drug therapy for kidney diseases - Apr 27, 2011
- Inflammation may provide breeding ground for cancer - Apr 20, 2011
- Anti-hypertensive drug improves multiple sclerosis-related brain inflammation - Jul 29, 2010
- Manipulating muscle stem cells could treat muscular dystrophy - Oct 10, 2010
Tags: blood clots, blood clotting factor, cancer cells, cancer patients, causes of death, cellular machinery, embl, enigmatic relationship, european molecular biology, european molecular biology laboratory, gene regulation, heidelberg germany, heidelberg medical, leading causes of death, mapk, medical centre, molecular biology laboratory, molecular medicine, septicaemia, university of heidelberg